ASB12
Ankyrin repeat and SOCS box protein 12
Also known as: ASB12_HUMAN, FLJ39577
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WXK4
- Gene
- ASB12
- Ensembl
- ENSG00000198881
- Chromosome
- X
- Canonical length
- 309 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the ankyrin repeat and SOCS box-containing (ASB) family of proteins. They contain ankyrin repeat sequence and a SOCS box domain. The SOCS box serves to couple suppressor of cytokine signalling (SOCS) proteins and their binding partners with the elongin B and C complex, possibly targeting them for degradation. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
309 residues, UniProt reviewed canonical sequence.
>Q8WXK4|ASB12
1 MNLMDITKIF SLLQPDKEEE DTDTEEKQAL NQAVYDNDSY TLDQLLRQER YKRFINSRSG
61 WGVPGTPLRL AASYGHLSCL QVLLAHGADV DSLDVKAQTP LFTAVSHGHL DCVRVLLEAG
121 ASPGGSIYNN CSPVLTAARD GAVAILQELL DHGAEANVKA KLPVWASNIA SCSGPLYLAA
181 VYGHLDCFRL LLLHGADPDY NCTDQGLLAR VPRPRTLLEI CLHHNCEPEY IQLLIDFGAN
241 IYLPSLSLDL TSQDDKGIAL LLQARATPRS LLSQVRLVVR RALCQAGQPQ AINQLDIPPM
301 LISYLKHQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASB12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 85 nTPM
- tongue: 49 nTPM
- heart muscle: 3.3 nTPM
- testis: 1.6 nTPM
- fallopian tube: 1.3 nTPM
- blood vessel: 0.9 nTPM
Single-cell type
- late spermatids: 40 nCPM
- early spermatids: 6.9 nCPM
- myonuclei: 5.1 nCPM
- cone photoreceptor cells: 2.1 nCPM
- thymocytes: 1.7 nCPM
- thymic myoid cells: 1.4 nCPM
Immune cell
- basophil: 1.1 nTPM
- T-reg: 0.3 nTPM
- naive B-cell: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- midbrain: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- amygdala: 0.3 nTPM
- basal ganglia: 0.3 nTPM
- cerebellum: 0.3 nTPM
- choroid plexus: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.93
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ASB12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASB12 as an antibody target. Whether an autoantibody or antibody against ASB12 could matter depends on whether native ASB12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASB12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASB12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...